Literature DB >> 19726084

The TCL1 mouse as a model for chronic lymphocytic leukemia.

Terry J Hamblin1.   

Abstract

The TCL1 mouse has been proposed as a mouse model for chronic lymphocytic leukemia. This review details how it resembles the aggressive form of the disease rather than the more common indolent form. Although fulfilled predictions in the human disease based on investigations in the mouse model are at present lacking, there are remarkable similarities between human and mouse leukemias that have led to interesting observations on the pathophysiology of chronic lymphocytic leukemia and have identified putative therapeutic targets. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726084     DOI: 10.1016/j.leukres.2009.08.004

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Spontaneous transformation of murine epithelial cells requires the early acquisition of specific chromosomal aneuploidies and genomic imbalances.

Authors:  Hesed M Padilla-Nash; Karen Hathcock; Nicole E McNeil; David Mack; Daniel Hoeppner; Rea Ravin; Turid Knutsen; Raluca Yonescu; Danny Wangsa; Kathleen Dorritie; Linda Barenboim; Yue Hu; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2011-12-08       Impact factor: 5.006

2.  BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia.

Authors:  Yo-Ting Tsai; Aparna Lakshmanan; Amy Lehman; Bonnie K Harrington; Fabienne McClanahan Lucas; Minh Tran; Ellen J Sass; Meixiao Long; Alan D Flechtner; Florinda Jaynes; Krista La Perle; Vincenzo Coppola; Gerard Lozanski; Natarajan Muthusamy; John C Byrd; Michael R Grever; David M Lucas
Journal:  Blood Adv       Date:  2017-10-30

3.  Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.

Authors:  D J DiLillo; J B Weinberg; A Yoshizaki; M Horikawa; J M Bryant; Y Iwata; T Matsushita; K M Matta; Y Chen; G M Venturi; G Russo; J P Gockerman; J O Moore; L F Diehl; A D Volkheimer; D R Friedman; M C Lanasa; R P Hall; T F Tedder
Journal:  Leukemia       Date:  2012-07-13       Impact factor: 11.528

4.  Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival.

Authors:  Chih-Hang Anthony Tang; Sujeewa Ranatunga; Crystina L Kriss; Christopher L Cubitt; Jianguo Tao; Javier A Pinilla-Ibarz; Juan R Del Valle; Chih-Chi Andrew Hu
Journal:  J Clin Invest       Date:  2014-05-08       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.